Gamithromycin|145435-72-9|-陌孚医药/Medlife

您当前的位置：

Gamithromycin

目录号: PL12092 纯度: ≥98.0%

CAS No. :145435-72-9

商品编号	规格	价格	会员价
PL12092-2mg	2mg	¥964.00	请登录
PL12092-5mg	5mg	¥1382.00	请登录
PL12092-10mg	10mg	¥1417.50	请登录
PL12092-50mg	50mg	¥6230.00	请登录
PL12092-100mg	100mg	¥11060.00	请登录
PL12092-200mg	200mg	询价	询价
PL12092-500mg	500mg	询价	询价
PL12092-10mM*1mLinDMSO	10mM*1mLinDMSO	¥2060.00	请登录

Medlife所售产品仅用于科学研究（非临床研究），非药品不可食用，不可用于人体或动物的临床诊断和治疗，我们不为个人提供产品及服务。产品COA等资料，可至下方“质量控制”中下载。

加入购物车在线咨询收藏产品大包装询价

中文名称	Gamithromycin
中文别名	加米霉素;加米霉素原药
英文名称	Gamithromycin
英文别名	Gamithromycin;(2R,3S,4R,5S,8R,10R,11R,12S,13S,14R)-13-[(2,6-dideoxy-3-Cmethyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-7-propyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy]-1-oxa-7-azacyclopentadecan-15-one;(2R,3S,4R,5S,8R,10R,11R,12S,13S,14R)-13-[(2,6-dideoxy-3-Cmethyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-7-propyl-11-[[3,4,6-trideoxy-3-(dimethylamino;ZE856183S0;Gamithromycin [USAN:INN];ML 1709460;C40H76N2O12;7184AA;435G729
Cas No.	145435-72-9
分子式	C₄₀H₇₆N₂O₁₂
分子量	777.04
包装储存	Powder -20°C 3 years；4°C 2 years

产品详情	Gamithromycin 是一种可以抑制 MmmSC 菌株 B237 和 Tan8 生长的抗菌剂，MIC 值分别为 0.00012 和 0.00006 μg/mL。
生物活性	Gamithromycin is an antimicrobial agent which can inhibit the growth of MmmSC strains B237 and Tan8 with MICs of 0.00012 and 0.00006 μg/mL, respectively.
性状	Solid
IC50 & Target[1][2]	MIC: 0.00012 μg/mL (MmmSC strain B237), 0.00006μg/mL (MmmSC strain Tan8)
体外研究(In Vitro)	The MIC values in serum are significantly lower than those in artificial medium; at an initial inoculum size of 10 cfu/mL, these are 64-, 8- and 64-fold lower for gamithromycin, tylosin and tilmicosin, respectively, against MmmSC strain B237 in serum compare to artificial medium. A similar pattern emerges for Tan8. Heat-inactivation of serum results in an MIC for gamithromycin that is higher than in either non-treated serum or artificial medium. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)	The proportion of foals that recover without the need for a change in treatment is significantly (P<0.048) higher for foals treated with Gamithromycin (GAM) (38 of 40; 95%) or AZM-RIF (39 of 40; 98%) compare to control foals (32 of 41; 78%). The clinical scores, number of abscesses and the abscess scores after 1 and 2 weeks of treatment are significantly lower for foals treated with Gamithromycin (GAM) or AZM-RIF compare to control foals. The WBC count of foals treated with Gamithromycin (GAM) is significantly higher than that of foals treated with AZM-RIF on week 3 of treatment. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件	Room temperature in continental US; may vary elsewhere.
储存方式	Powder -20°C 3 years；4°C 2 years
参考文献	[1]. Mitchell JD, et al. In vitro pharmacodynamics of gamithromycin against Mycoplasma mycoides subspecies mycoides Small Colony. Vet J. 2013 Sep;197(3):806-11. [2]. F. Hildebrand, et al. Efficacy of Gamithromycin for the Treatment of Foals with Mild to Moderate Bronchopneumonia. J Vet Intern Med. 2015 Jan-Feb; 29(1): 333–338.

溶解度数据	In Vitro: DMSO : 100 mg/mL (128.69 mM; Need ultrasonic)配制储备液

搜索质检报告(COA)

产品使用指南

Data Sheet

1：一般建议：溶解度为Medlife测试数据，可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解，请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异，仅做参考，具体以实验方案为准。

2：储存条件：粉末-20°C一般情况可以保存3年，溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异，请细致阅读产品信息，并辅助参考相关文献描述。

相关产品

The molarity calculator equation

The dilution calculator equation